Blood Screening Market Is Predicted To Reach USD 3.9 Billion By 2024:By Grand View Research, Inc.
The global blood screening market is expected to reach a
value of USD 3.9 billion by 2024, based on a new report by Grand View Research,
Inc. The growth of the market is attributed to the increasing screening of
donor and continuous technological advancements by the market players. Demand
for blood screening tests are increasing continuously due to increasing
donation, rising awareness about transfusion-transmitted diseases, and
technological developments in the industry.
Thorough screening is necessary for all donated blood to
ensure that recipients receive the safest products. As of 2015, such testing
consists of screening for red cell antibodies, and the infectious diseases
agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human
T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis).
Result of all these assays must be negative for blood donation.
Technological developments in the market increase the
sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA
approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen
donated blood. Furthermore, the U.S. FDA approved next-generation sequencing
(NGS) technology in 2013. The technology is cheaper and faster than previous
DNA analysis methods.
Browse full research report on Blood Screening Market:
http://www.grandviewresearch.com/industry-analysis/blood-screening-market
Further Key Findings from the Study Suggest:
- Nucleic
acid amplification test or nucleic acid test (NAT) is expected to be the
fastest growing segment during the forecast period. It comprises
transcription mediated amplification (TMA) tests and polymerase chain
reaction. Increasing demand of NAT over ELISA test due to high sensitivity
and specificity for viral nucleic acid is contributing to the fastest
growth during the forecast period.
- In
2015, reagent dominated the product segment. Introduction of new assays
for the detection of various diseases is expected to enable the segment to
gain the maximum share of market in the coming years. For instance, in
January 2015 the FDA approved Roche’s blood screening assay COBAS
TaqScreen MPX Test for the detection and identification of HCV, HIV, and
HBV.
- In 2015,
regionally North America dominated with a revenue share of more than 40%.
Government initiatives, presence of major players, and more patient
affordability are the major factors that contributed toward its dominance.
- In
August 2016, the FDA recommended the testing of all the donated blood in
the U.S. and its territories for Zika virus in order to prevent
transmission of this virus through the blood supply.
- Asia
Pacific is expected to be the fastest growing region due to increasing
investment of industry players, government initiatives, and rising
awareness about transmission of diseases during its transfusion.
- The
Red Cross in Japan entered into a contract with Grifols for nucleic acid
testing (NAT) for a blood donation camp in Japan in 2014. This agreement
is anticipated to propel the NAT market during the forecast period.
However, low donation as compared to requirement and high cost of kits and
instruments are likely to restrain the growth in low-income countries
during the forecast period.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the blood screening market
by technology, product and region:
Blood Screening Market Technology Outlook (Market
Revenue in USD Million, 2013 - 2024)
- Nucleic
Acid Amplification Test (NAT)
- ELISA
- Chemiluminescence
Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
- Next-Generation
Sequencing (NGS)
- Western
Blotting
Blood Screening Market Product Outlook (Market
Revenue in USD Million, 2013 - 2024)
- Reagent
- Instrument
Blood Screening Market Regional Outlook (Market
Revenue in USD Million, 2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Middle
East and Africa
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-blood-screening-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
Comments
Post a Comment